BNIP3 interacting with LC3 triggers excessive mitophagy in delayed neuronal death in stroke
However, folate supplementation can mask these haematological changes whilst neurological damage continues, highlighting the importance of checking B12 status before commencing folate therapy
Tirzepatide is not recommended in patients with severe gastrointestinal disease, including severe gastroparesis, as further slowing of gastric emptying could exacerbate symptoms

Practical steps that may help include: Keeping an updated list of every medication, vitamin, and supplement currently being taken Reporting new symptoms such as dizziness, unusual fatigue, or shakiness promptly to a provider Avoiding starting or stopping other medications without first discussing it with a prescriber Following the prescribed injection schedule consistently, since irregular timing can make side effects harder to track Asking about blood sugar monitoring frequency if insulin or a sulfonylurea is also part of the treatment plan A pattern many providers notice in practice is that patients who are newly combining Semaglutide with insulin often experience mild blood sugar dips in the first two to three weeks, before dosing is fine-tuned, which is part of why early monitoring tends to matter more than people expect
Proper storage is essential to preserve peptide integrity and reproducibility in research applications